Elixirgen Scientific, Inc.
|
Year Established:
2016 |
|
|
Website:
elixirgensci.com |
|
|
Headquarters:
Baltimore, MD, US |
|
|
Company Type:
Mid-Sized Business (10-100M TTM Revenue) |
Elixirgen Scientific, established in 2016, is a Maryland-based biotechnology firm specializing in iPSC-related technology. Our mission is to dedicate ourselves to quality, innovation, and collaboration, which drives the development of cutting-edge discoveries and therapies through the power of iPSC technology.
We are focused on:
● New Cell Type Development Partnership:
Engage in a strategic partnership focused on creating clinically relevant and functional cells. These cells find applications in neurodegenerative drug screening and cell therapy, contributing to the evolution of medical solutions.
●Cell Supply Agreement for Drug Screening:
Ensure the efficiency of your drug discovery pipeline with our reliable and consistent supply of cells for screening purposes. We prioritize the seamless progression of your research and development initiatives.
●Translational Research Partnership with Patient-Derived Disease Model:
Collaborate with us in translational research, benefitting from disease panel assays tailored to your specific needs. Our expertise extends to diseases such as Alzheimer’s, Parkinson’s, rare diseases and regenerative medicine.
| Site | Badges | |
|---|---|---|
| Elixirgen Scientific Japan, Inc. Shonan Health Innovation Park, 2-26-1, Muraoka-Higashi Fujisawa, Kanagawa, 251-8555 Japan | ||
| Elixirgen Scientific, Inc. 855 N. Wolfe St., Suite 631 Baltimore, MD, 21205 United States | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.